← Leaderboards
Philip Arthur Band
Cytodel, Inc.
$934,229
Attributed
$934,229
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $433.7K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$934,229 · 3
By mechanism
R43$710,289 · 2
R41$223,940 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Success”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$277,058,716
- Lawrence Corey · Fred Hutchinson Cancer Center$274,406,165
- Barton F Haynes · Duke University$260,353,372
Research focus
SuccessMuscleRecombinantsStability TestingReportingAmino Acid SubstitutionLabelPharmacologic SubstanceDigitalSafetyEffectivenessResponseEngineeringCerebral PalsyDoseCellsLeadEnzyme-Linked Immunosorbent AssayExhibitsChildhoodCessation Of LifeCharacteristicsFormulationBotulinum Toxins
Grant awards (4)
Development of B8C1ad as an Orphan Drug for Iatrogenic Botulism$295,365
R43 · FY2023 · NS · contact PI
Recombinant botulinum toxin with improved safety and effectiveness for treatment of dystonia$138,307
R43 · FY2023 · NS · contact PI
Recombinant botulinum toxin with improved safety and effectiveness for treatment of dystonia$276,617
R43 · FY2022 · NS · contact PI
Recombinant Botulinum Neurotoxin for Treatment of Spastic Disorders$223,940
R41 · FY2014 · NS · contact PI